30
Views
6
CrossRef citations to date
0
Altmetric
Anticancer Chemotherapy

Pharmacokinetics of Mitomycin C after Resection of Peritoneal Carcinomatosis and Intraperitoneal Chemohyperthermic Perfusion

Pages 668-673 | Published online: 18 Jul 2013

References

  • Markman M. Intraperitoneal chemotherapy in the man-agement of colon cancer. Semin Oncol 1999; 26 (2): 536–539.
  • Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyper-thermic chemotherapy. Cancer Res 1980; 40 (2): 256–260.
  • Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000; 87 (8): 1006–1015.
  • Gilly FN, Beaujard A, Glehen O et al. Peritonectomy combined with intraperitoneal chemohyperthermia in abdomi-nal cancer with peritoneal carcinomatosis: phase I-II study. Anticancer Res 1999; 19 (3B): 2317-2321.
  • Sugarbaker PH, Cunliffe W, Belliveu J et al. Rationale for early postoperative intraperitoneal chemotherapy as a sur-gical adjuvant for gastrointestinal malignancy. Reg Canc Treat 1989; 1: 66–79.
  • Beujard AC, Glehen O, Caillot JL et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract can-cer patients with peritoneal carcinomatosis. Cancer 2000; 88 (11): 2512–2519.
  • Sugarbaker PH, Cunliffe W, Belliveu J et al. Rationale for integrating early postoperative intraperitoneal chemothera-py into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989; 16: 83–97.
  • Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 2001; 27 (6): 365–374.
  • Keller E, Reetze P, Schollmeyer P. Drug therapy in patients undergoing continues ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1990; 18 (2): 104–117.
  • Paroni R, Arcelloni C, De Vecchi E, Fermo I, Mauri D, Colombo R. Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction. Clin Chem 1997; 43 (4): 615–18.
  • de Lima Vazquez V, Stuart OA, Mohamed F, Sugarbaker PH. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol. 2003; 52 (2): 108–12.
  • van Ruth S, Mathot RA, Sparidans RW, Beijnen JH, Verwaal VJ, Zoetmulder FA. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyper-thermic intraperitoneal chemotherapy. Clin Pharmacokinet. 2004; 43 (2): 131–43.
  • den Hartigh J, Mc Vie JG, van Ourt WJ, Pinedo MH. Pharmacokinetics of mitomycin C in humans. Cancer Res 1982; 43: 5017–5021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.